Introducing the new King of the PBS
Strong growth for some drugs, sharp falls and lost exclusivity for others means the Top 10 PBS Earners list looks very different than a year ago
Strong growth for some drugs, sharp falls and lost exclusivity for others means the Top 10 PBS Earners list looks very different than a year ago
New report lifts the lid on what rival sales reps are telling HCPs to differentiate their competing blockbuster products
An expanded PBS listing has been leapt upon by HCPs and patients, seeing reimbursements skyrocket
Health Minister says this “revolutionary class of drugs” must be subsidised but price negotiations have hit a wall
Aussie leader unveils his next career move after departing a top US-based role at J&J a fortnight ago
There has been a seismic shift in Country Leadership in Australia with 21 ANZ bosses departing in just 12 months
A meteoric rise to the top for this former MD who has gone from Franchise Head to Country Head in just 10 months
The Swiss pharma giant has expanded its offerings in haematology and ophthalmology
Peak industry body looks to shift focus from reacting to shortages to preventing them before they occur
Pharma's not alone in feeling frustration over timely access to medicines, doctors feel the pain too and want industry to fix it
CEO of the Australian business says the achievement belongs to the people who bring the company's values to life